Recent

% | $
Quotes you view appear here for quick access.

PharmAthene, Inc. Message Board

  • adspatz adspatz Dec 2, 2013 11:16 AM Flag

    PharmAthene terminates merger with Theraclone Sciences

     

    Search for "SEC Live Filings Digest" to find out more.
    PharmAthene, Inc. (PIP) has terminated its merger agreement with Theraclone Sciences, Inc., after reaching an agreement with Theraclone. Had the merger been executed, a wholly-owned subsidiary of PharmAthene would have merged with Theraclone in an all-stock deal. Because PharmAthene has now cancelled the merger and its special meeting with shareholders, it will pay Theraclone a termination fee in the amount of $1M. PharmAthene is a bio-defense company that specializes in medical countermeasures to biological and chemical threats. Its flagship products include countermeasures for anthrax and nerve agents. PharmAthene President and CEO Eric Richman expressed his gratitude for the hard work put forth by both companies during the last several months to close the transaction and affirmed its enthusiasm to identify opportunities to provide shareholders maximum value.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PIP
2.53-0.02(-0.78%)Jul 22 4:01 PMEDT